A Study of the Prevalence, Socio-Demographic and Clinical Correlates of Metabolic Syndrome (M S) in Drug-naive Patients of Anxiety and Depressive Disorders.

ABSTRACT

Backgroud The prevalence of Metabolic Syndrome (MS) and its components is reported to be higher in population with mental illness as compared to general population across al diagnostic categories. There is a paucity of studies on the baseline prevalence of MS and its these studes have produced mixed results. The present study was therefore carried out in patients attending the out-patient (OPD) psychiatry department. Aims and Objective:To find out and compare the prevalence and socio-demographic and clinical correlates of MS in drug native patients of anxiety and depressive disorders. Materials and Methods: Socio-demographic details, were collected and analyzed using appropriate statistical tools. Results and Conclusions: The overall prevalence of metabolic syndrome was 23.5% while it was 46.2% in the depressive group and 9.5% in the anxiety group. 50% of the sample fulfilled at least one criterion for MS. While age, all MS components predicted MS overall; HDL, waist circumference and BMI predicted MS in depressive patient and HDL and triglyceride abnormalities predicted MS in the anxiety group.